Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.48
-0.02 (-4.57%)
At close: Jun 13, 2025, 3:59 PM

Sangamo Therapeutics Revenue

Sangamo Therapeutics reported an annual revenue of $57.8M, reflecting a -67.2% growth. For the quarter ending March 31, 2025, Sangamo Therapeutics generated $6.44M in revenue.
Revenue (ttm)
$57.8M
Revenue Growth
-67.2%
Price / Sales Ratio
3.56
Revenue / Employee
$315.85K
Employees
183
Market Cap
118.21M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.